IDA blend vs Maldives: Cause of death, by non-communicable diseases, male
IDA blend
38.3%
in 2021
Maldives
76.3%
in 2021
IDA blend rank
38th
Maldives rank
35th
Cause of death, by non-communicable diseases, male over time
- IDA blend
- Maldives
How they compare
Maldives currently reports 76.3% against 38.3% in IDA blend, a difference of 38.0%.
That makes Maldives's figure about 2.0 times IDA blend's.
Across all 6 years both countries report, Maldives has been ahead every year.
IDA blend ranks 38th and Maldives ranks 35th of 47 groups.
Maldives has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.8% | 73.6% | 44.7% | Maldives |
| 2010s | 37.4% | 85.3% | 47.9% | Maldives |
| 2020s | 39.0% | 80.0% | 41.0% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, IDA blend or Maldives?
- Maldives, at 76.3% against 38.3% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between IDA blend and Maldives?
- 38.0%, with Maldives ahead.
- How many years of comparable data are there for IDA blend and Maldives?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Maldives rank globally for cause of death, by non-communicable diseases, male?
- IDA blend ranks 38th and Maldives ranks 35th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.